Thermoflex system

Thermoflex system

Urology A water-induced thermotherapy system for treating BPH and associated urinary obstruction. See Benign prostatic hypertrophy.
References in periodicals archive ?
Under this arrangement, Quintiles, through its corporate ventures group, PharmaBio Development, will provide ArgoMed with a convertible line of credit to establish a sales force to launch and promote the Thermoflex System in the United States.
Food and Drug Administration to market the Thermoflex System in the United States for the treatment of BPH.
This new infusion of capital comes only months after ArgoMed raised $3 million in a private equity round, and launched its Thermoflex System in the U.
The Thermoflex System is the first and only product in the U.
Carefully monitored clinical studies indicate that the Thermoflex System results in significant improvement of urinary flow rate.
The Thermoflex System is currently available in select East Coast cities and has been sold in Europe since mid-1998.
The Thermoflex System represents a new, effective, and low-cost treatment option for the millions of men with BPH, a non-malignant enlargement of the prostate gland common in older men.
Argomed's new water-induced thermotherapy (WIT) procedure, administered by the Thermoflex System, is a simple, low-cost, pain-free therapy that requires no sedation.
The Thermoflex System circulates heated water, precisely controlled at 60 degrees C, through a proprietary catheter, thereby destroying obstructive prostatic tissue.
In addition, the Thermoflex system requires only topical anesthetic gel and can be performed in a physician's office, thereby eliminating risks associated with general anesthesia.
At Drupa, CreoScitex is performing a technology demonstration of sleeve-handling on the wide-web ThermoFlex system.
Argomed's first product, the Thermoflex system, is sold internationally to treat the symptoms of prostate obstruction or BPH.